Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Nakshatri

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Cell Death & Disease|January 23, 2015
NF-κB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPTH Nakshatri, H N Appaiah, M Anjanappa, et al.
Blood|September 25, 1998
Regulation of the c-jun gene in p210 BCR-ABL transformed cells corresponds with activity of JNK, the c-jun N-terminal kinaseG S Burgess, E A Williamson, L D Cripe, et al.
Oncogene|August 30, 2000
Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolideN M Patel, S Nozaki, N H Shortle, et al.
Oncogene|November 9, 2010
Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22J B Patel, H N Appaiah, R M Burnett, et al.
Oncogene|September 12, 2017
A system for detecting high impact-low frequency mutations in primary tumors and metastasesM Anjanappa, Y Hao, E R Simpson, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Cell Death & Disease|January 23, 2015
NF-κB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPTH Nakshatri, H N Appaiah, M Anjanappa, et al.
Blood|September 25, 1998
Regulation of the c-jun gene in p210 BCR-ABL transformed cells corresponds with activity of JNK, the c-jun N-terminal kinaseG S Burgess, E A Williamson, L D Cripe, et al.
Oncogene|August 30, 2000
Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolideN M Patel, S Nozaki, N H Shortle, et al.
Oncogene|November 9, 2010
Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22J B Patel, H N Appaiah, R M Burnett, et al.
Oncogene|September 12, 2017
A system for detecting high impact-low frequency mutations in primary tumors and metastasesM Anjanappa, Y Hao, E R Simpson, et al.
Pageof 5